Labcorp HoldingsLTS:0JSY 81 5-Year ROIIC % is 110.87 as of Dec. 2025. GuruFocus rates LTS:0JSY with a GF Score™ of 81/100 and a GF Value™ of $270.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Labcorp Holdings ranks better than 90.53% on this metric.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Labcorp Holdings's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 110.87%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Labcorp Holdings's 5-Year ROIIC % or its related term are showing as below:
LTS:0JSY's 5-Year ROIIC % is ranked better than 90.53% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: -2.185
vs LTS:0JSY: 110.87
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Labcorp Holdings 5-Year ROIIC % Related Terms
Labcorp Holdings 5-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Labcorp Holdings's 5-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0JSY vs DGX, GH, MTD: 5-Year ROIIC % Comparison
For the Diagnostics & Research subindustry, Labcorp Holdings's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labcorp Holdings 5-Year ROIIC % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Labcorp Holdings's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Labcorp Holdings's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Labcorp Holdings (LTS:0JSY) has a 5-Year ROIIC % of 110.87 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Labcorp Holdings and its competitors. According to the industry distribution chart, Labcorp Holdings ranks #18 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 9.5%.
Is Labcorp Holdings' 5-Year ROIIC % too high?
Labcorp Holdings' current 5-Year ROIIC % is 110.87. Based on the distribution chart, Labcorp Holdings ranks #18 out of 190 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Labcorp Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labcorp Holdings' 5-Year ROIIC % compare to DGX and GH?
According to the Medical Diagnostics & Research industry distribution chart, Labcorp Holdings ranks #18 out of 190 companies for 5-Year ROIIC %. This places Labcorp Holdings in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Medical Diagnostics & Research company?
A good 5-Year ROIIC % depends on the Medical Diagnostics & Research industry context. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Labcorp Holdings and its competitors. Labcorp Holdings's current 5-Year ROIIC % is 110.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labcorp Holdings stock overvalued right now?
Based on GuruFocus' analysis, Labcorp Holdings (LTS:0JSY) is currently considered Fairly Valued. The stock's GF Value™ is $270.22, compared to a current price of $285.29 — trading 5.6% above its estimated fair value. The current 5-Year ROIIC % is 110.87. Labcorp Holdings' overall GF Score™ is 81/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Labcorp Holdings (LTS:0JSY), the current 5-Year ROIIC % is 110.87 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labcorp Holdings (LTS:0JSY) Overvalued in 2026?
Based on GuruFocus' analysis, Labcorp Holdings stock appears to be overvalued.
The current stock price of $285.29 is trading 5.6% above its estimated GF Value™ of $270.22.
GuruFocus considers Labcorp Holdings to be Fairly Valued.
Key valuation signals for LTS:0JSY:
5-Year ROIIC %: 110.87
GF Value™: $270.22 vs. price of $285.29 (5.6% above fair value)
No single metric tells the full story. See the LTS:0JSY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
81GF Score
Get the complete analysis for LTS:0JSY
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0JSY has been successfully added to your 
